• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Authors » Conor Hale

Conor Hale

Articles

ARTICLES

Industry Approaching Inflection Point in Consolidation Towards Large Health Systems

April 9, 2018
Conor Hale
The clinical research business is approaching an inflection point similar to the shifts seen over the past 25 to 30 years, only now the trends are toward consolidation in larger health systems and their affiliates that can take a more patient-centric approach, according to Ken Getz, director of sponsored research programs at the Tufts University Center for the Study of Drug Development. Read More

Mandated Restructuring of Informed Consent Documents Could Help Guide Patient Decision-Making

April 2, 2018
Conor Hale
The revised Common Rule, scheduled to take effect July 19, includes new requirements for the structure of informed consent documents, including that they begin with a concise presentation of the form’s essential points — a change that could turn the form into a tool that can help guide a patient’s clinical decision-making. Read More

Best Practices in Site Feasibility Studies Can Set the Stage for a Healthy Trial

April 2, 2018
Conor Hale
Well-performed, confident site feasibility studies, at times a tedious, thankless task, can become the single most important factor in reducing costs and time spent during a clinical trial, according to Wes Martz, associate director of ePharmaSolutions’ clinical services division. Read More

FDA Previews Pilot Program to Provide Early Regulatory Review of Innovative Trial Designs

March 26, 2018
Conor Hale
The FDA previewed an upcoming pilot project that offers sponsors initial reviews of protocols for clinical trials with highly complex, innovative designs — including adaptive studies, master protocols and basket trials, as well as those using Bayesian statistics or computer simulations to determine operations. Read More

FDA Releases First Clinical Study Report in Data Transparency Pilot Program

March 26, 2018
Zack Budryk and Conor Hale
The FDA published its first batch of clinical data summary documents under a transparency pilot program launched earlier this year. Read More

CTTI Investigates Barriers to Conducting Pediatric Antibacterial Clinical Trials

March 12, 2018
Conor Hale
Pediatric antibacterial drug trials currently account for less than one percent of all interventional and observational pediatric studies registered on ClinicalTrials.gov between October 2007 and September 2015, or only 82 out of 12,703. Read More

National Academies Workshop Suggests Principles for Use of Real-World Evidence

March 12, 2018
Conor Hale
Experts convened at the National Academies of Sciences, Engineering and Medicine to examine how the uptake of real-world evidence will impact medical product development, recommending producers and consumers of evidence focus on maintaining transparency, accountability and reproducibility of results. Read More

Free Online Transparency Tool Tracks Clinical Trials Reporting Compliance

March 5, 2018
Conor Hale
The FDAAA TrialsTracker, an online tool that charts whether individual sponsors report their study results on ClinicalTrials.gov in compliance with federal laws and regulations, launched Feb. 19. The data transparency project was developed by the University of Oxford’s Evidence-Based Medicine DataLab, and is available to the public. Read More

Challenges Become More Concentrated in Gene Therapy Development, Experts Say

March 5, 2018
Conor Hale
Experts came together to speak at a WCG Rare Disease Day webinar on the main scientific and ethical considerations of research in rare and ultra-rare diseases, the majority of which are driven by hereditary genetic mutations. Read More

Mayo Clinical Reports Treatment Benefits May Be Exaggerated in Early Clinical Trial Results

March 5, 2018
Conor Hale
The first two randomized controlled trials of treatments of chronic medical conditions are much more likely to overstate any beneficial effects when compared to later clinical research, according to a group led by researchers from the Mayo Clinic, which urged regulators to be wary of data from early studies in a product’s chain of evidence. Read More
View All Articles by Conor Hale

Upcoming Events

  • 06Jun

    Gene & Cell Therapy Regulation: Comparability and Other New Developments

  • 07Jun

    Developing World-Class SOPs: Optimizing Quality and Compliance

  • 08Jun

    Implementing ICH E8 R1 Recommendations Increases Site and Participant Relationship Scoring Measures

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing